Filter
5708
Filtered Results: 5708
Text search:
burden
of
disease
Featured
Recommendations
463
New Publications
1380
Language
Document type
No document type
3004
Studies & Reports
1291
Guidelines
624
Strategic & Response Plan
253
Manuals
233
Fact sheets
138
Training Material
69
Situation Updates
28
Infographics
25
Resource Platforms
23
Brochures
7
Dashboards/Maps
5
Online Courses
5
Videos
3
Countries / Regions
Global
361
India
259
Kenya
178
Western and Central Europe
143
South Africa
138
Ethiopia
117
Africa
110
Latin America and the Carribbean
103
Uganda
97
Nigeria
94
Sierra Leone
90
Liberia
85
Tanzania
81
Nepal
78
Malawi
78
Zambia
72
Bangladesh
68
Ghana
67
Rwanda
61
Ukraine
61
Eastern Europe
60
Namibia
54
Myanmar / Burma
53
Syria
49
South–East Asia Region
49
Asia
49
Philippines
41
Mozambique
39
Zimbabwe
34
East and Southern Africa
34
Cambodia
33
Congo, Democratic Republic of
32
Russia
32
South Sudan
31
Lesotho
31
Indonesia
30
West and Central Africa
29
Brazil
28
Guinea
23
Botswana
23
Eastern Europe and Central Asia
22
Senegal
20
Germany
20
Middle East and North Africa
20
Pakistan
19
Eswatini/ Swaziland
17
Haiti
16
Burkina Faso
15
Sudan
15
Cameroon
14
Yemen
14
North America
14
Colombia
13
Western Pacific Region
13
USA
12
Venezuela
12
Afghanistan
11
Somalia
10
Thailand
10
Vietnam
10
Jordan
8
Benin
8
Central African Republic
8
Albania
8
Tajikistan
8
Iraq
7
Argentina
7
Peru
7
Chile
7
Moldova
7
Mali
6
Lebanon
6
Ecuador
6
Madagascar
6
Sri Lanka
6
Southern Africa
6
Laos
6
Georgia
6
North Macedonia
5
Mexico
5
Paraguay
5
Palestine
5
Iran
5
Jamaica
5
Saudi Arabia
4
Turkey
4
Egypt
4
China
4
Burundi
4
Libya
4
Angola
4
Armenia
4
Timor Leste/ East Timor
4
Greece
3
Poland
3
Romania
3
Kyrgyzstan
3
Turkmenistan
3
Mauritius
3
United Kingdom
3
Belarus
3
Guinea-Bissau
2
Côte d’Ivoire / Ivory Coast
2
Papua New Guinea
2
Switzerland
2
Other region
2
Bhutan
2
Djibouti
2
Qatar
2
Kazakhstan
2
Gabon
2
Tunisia
2
Bosnia and Herzegovina
2
Morocco
1
Niger
1
Togo
1
Chad
1
Gambia
1
Ireland
1
Hungary
1
Honduras
1
El Salvador
1
Bolivia
1
Guatemala
1
North Korea
1
Mongolia
1
Canada
1
Bulgaria
1
Estonia
1
Slovakia
1
Japan
1
Denmark
1
Belgium
1
France
1
Maldives
1
Portugal
1
Spain
1
Morocco
1
Azerbaijan
1
Barbados
1
Authors & Publishers
Publication Years
Category
Countries
2043
Clinical Guidelines
531
Public Health
498
Women & Child Health
209
Key Resources
173
Capacity Building
66
Pharmacy & Technologies
37
Annual Report MEDBOX
2
Toolboxes
TB
503
HIV
484
Mental Health
460
COVID-19
414
NCDs
295
Planetary Health
265
AMR
217
NTDs
213
Disability
141
Global Health Education
133
Caregiver
130
Rapid Response
119
Conflict
111
Ebola
80
Health Financing Toolbox
76
Refugee
71
Pharmacy
58
Natural Hazards
41
Polio
29
Cholera
28
Zika
18
Social Ethics
18
Specific Hazards
15
South Sudan
1
Health Financing
1
Age-standardized cardiovascular disease (CVD) mortality rates by region ranged from 73.6 per 100,000 in High-income Asia Pacific to 432.3 per 100,000 in Eastern Europe in 2022. Global CVD mortality decreased by 34.9% from 1990 to 2022. Ischemic hear...
The global burden of disease (GBD) study provides information about fatal and non-fatal health outcomes around the world.
The objective ... this work is to describe the burden of mental disorders among children aged 5–14 years in each of the six regions of the World Health Organisation. Data come from the GBD 2015 study. Outcomes: disability-adjusted life-years (DALYs) are the main indicator of GBD studies and are built from years of life lost (YLLs) and years of life lived with disability (YLDs).
Mycetoma is a chronic infectious disease of the subcutaneous tissue with a high morbidity. This disease has been reported from countries between 30...
Asthma is the most common chronic disease in children, imposing a consistent burden on health system. In recent years, prevalence of asthma symptom...
This report aims to improve the assessment of mental health needs in the Americas by providing an updated and nuanced picture of: (a) the disability resulting from mental, substance use, and specifi...
Asthma is the most common chronic disease in children globally. The Global Asthma Network (GAN) Phase I study aimed to determine if the worldwide burden o... asthma symptoms is changing.
This updated cross-sectional study used the same methods as the International study of Asthma and Allergies in Childhood (ISAAC) Phase III. Asthma symptoms were assessed from centres that completed GAN Phase I and ISAAC Phase I (1993–95), ISAAC Phase III (2001–03), or both. We included individuals from two age groups (children aged 6–7 years and adolescents aged 13–14 years) who self-completed written questionnaires at school. We estimated the 10-year rate of change in prevalence of current wheeze, severe asthma symptoms, ever having asthma, exercise wheeze, and night cough (defined by core questions in the questionnaire) for each centre, and we estimated trends across world regions and income levels using mixed-effects linear regression models with region and country income level as confounders.
Overall, 119 795 participants from 27 centres in 14 countries were included: 74 361 adolescents (response rate 90%) and 45 434 children (response rate 79%). About one in ten individuals of both age groups had wheeze in the preceding year, of whom almost half had severe symptoms. Most centres showed a change in prevalence of 2 SE or more between ISAAC Phase III to GAN Phase I. Over the 27-year period (1993–2020), adolescents showed a significant decrease in percentage point prevalence per decade in severe asthma symptoms (–0·37, 95% CI –0·69 to –0·04) and an increase in ever having asthma (1·25, 0·67 to 1·83) and night cough (4·25, 3·06 to 5·44), which was also found in children (3·21, 1·80 to 4·62). The prevalence of current wheeze decreased in low-income countries (–1·37, –2·47 to –0·27], in children and –1·67, –2·70 to –0·64, in adolescents) and increased in lower-middle-income countries (1·99, 0·33 to 3·66, in children and 1·69, 0·13 to 3·25, in adolescents), but it was stable in upper-middle-income and high-income countries.
Trends in prevalence and severity of asthma symptoms over the past three decades varied by age group, country income, region, and centre. The high worldwide burden of severe asthma symptoms would be mitigated by enabling access to effective therapies for asthma.
Tuberculosis (TB) is the deadliest infectious disease in most low- and middle-income countries, claiming more than 4,000 lives each day. The unprecedented COVID-19 pandemic has seriously impacted people with pre-existing health conditions. People wi...
INTRODUCTION: Lower extremity peripheral artery disease (PAD) is increasing in prevalence in low- and middle-income countries creating a large health care burden. Clinical management may require sub...
Global cardiovascular disease (CVD) burden is high and rising, especially in low-income and middle-income countries (LMICs). Focussing on 45 LMICs, we aimed to determine (1) the adult population’s...
Background: Worldwide, maternal hypertensive disorders complicate one in ten pregnancies. As a result of changes in the life styles of society, currently, it is becoming a common public life encount...
A worldwide increase in the prevalence of asthma has been reported in recent years. With an increase in prevalence comes an increased burden of ... in terms of morbidity, mortality and compromised quality of life. The economic burden in terms of utilisation of healthcare resources and limitation of the earning capacity of the individuals and families is an added problem. Various indicators such as disability-adjusted life years and healthy life years have been used to define the economic burden. The data from Asian countries regarding these parameters is scarce, underlining the need for systematic studies in these countries, especially those that are resource poor. The purpose of this review is to highlight the varying prevalence of asthma in Asia and to assess the likely economic burden for the future.
It is estimated that as many as 300 million people of all ages, and all ethnic backgrounds, suffer from asthma and the burden of this ... to governments, health care systems, families, and patients is increasing worldwide. In 1989 the Global Initiative for Asthma (GINA) program was initiated in an effort to raise awareness among public health and government officials, health care workers, and the general public that asthma was on the increase. The GINA program recommends a management program based on the best available scientific evidence to provide effective medical care for asthma tailored to local health care systems and resources.
Diabetes is a chronic, metabolic disease characterized by elevated levels of blood glucose (or blood sugar), which leads over time to serious damage to the heart, blood vessels, eyes, kidneys and ne...
Noncommunicable diseases (NCDs) are the principal cause of morbidity, disability and premature mortality in Azerbaijan. The most effective way to reduce the NCD ... is to prevent NCD development, by addressing thebehavioural risk factors underlying NCDs at the population and individual levels: smoking, alcohol use, excessive salt intake, low physical activity, overweight and obesity, and unhealthy diets. In Azerbaijan, a national survey of the prevalence of major NCD risk factors, aligned with the WHO-endorsed STEPwise approach to surveillance (STEPS) methodology, was conducted in 2017.
In order to target resources and drugs to reach trachoma elimination targets by the year 2020, data on the burden of disease are required. Using pr...
Chagas disease or American trypanosomiasis is, together with geohelminths, the neglected disease that causes more loss of years ... healthy life due to disability in Latin America. Chagas disease, as determined by the factors and determinants, shows that different contexts require different actions, preventing new cases or reducing the burden of disease. Control strategies must combine two general courses of action including prevention of transmission to prevent the occurrence of new cases (these measures are cost effective), as well as opportune diagnosis and treatment of infected individuals in order to prevent the clinical evolution of the disease and to allow them to recuperate their health. All actions should be implemented as fully as possible and with an integrated way, to maximise the impact. Chagas disease cannot be eradicated due because of the demonstrated existence of infected wild triatomines
in permanent contact with domestic cycles and it contributes to the occurrence of at least few new cases. However, it is possible to interrupt the transmission of Trypanosoma cruzi in a large territory and to eliminate Chagas disease
as a public health problem with a dramatic reduction of burden of the disease.
The article "The Rising Burden of Non-Communicable Diseases in the Americas and the Impact of Po...
J Clin Med . 2020 May 18;9(5):1517. doi: 10.3390/jcm9051517.
Chagas disease (CD) is a major burden in Latin America, expanding also to non-endemic countries. A gold standard to detect the CD causi...
Many features of the environment have been found to exert an important influence on cardiovascular disease (CVD) risk, progression, and severity. Changes in the environment due to migration to diffe...
BACKGROUND. Asthma is a heterogeneous condition characterised by chronic inflammation and variable expiratory airflow limitation, as well as airway reversibility. The burden of asthma in children is...
